CytomX Therapeutics, Inc. SEC filings CTMX

CytomX Therapeutics, Inc. has 800 filings in SEC EDGAR's recent list, going back to Sep 28, 2010. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

CytomX Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 27, 2026 Jul 24, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 22, 2026 Jun 17, 2026
8-K Current report
Material agreement
Jun 3, 2026 May 29, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Other events
Mar 19, 2026 Mar 17, 2026
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 11, 2025
8-K Current report
Other events
May 28, 2025 May 27, 2025
8-K Current report
Other events
May 13, 2025 May 12, 2025
8-K Current report
Results of operations, Other events
May 12, 2025 May 12, 2025
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Listing notice
Feb 26, 2025 Feb 24, 2025
8-K Current report
Officer or director change
Feb 3, 2025 Jan 30, 2025
8-K Current report
Exit or restructuring costs
Jan 6, 2025 Jan 6, 2025
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Officer or director change
Jun 17, 2024 Jun 12, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 17, 2024 May 15, 2024
8-K Current report
Other events
May 8, 2024 May 8, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 22, 2024 Mar 20, 2024
8-K Current report
Results of operations
Mar 11, 2024 Mar 11, 2024
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Material agreement
Aug 24, 2023 Aug 8, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Material agreement, Unregistered share sale
Jul 3, 2023 Jun 29, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 14, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
Mar 27, 2023 Mar 27, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
8-K Current report
Restatement
Feb 24, 2023 Feb 23, 2023
8-K Current report
Material agreement
Jan 5, 2023 Dec 30, 2022
8-K Current report
Material agreement
Nov 22, 2022 Nov 16, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Officer or director change
Sep 23, 2022 Sep 21, 2022
8-K Current report
Officer or director change
Sep 13, 2022 Sep 8, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Exit or restructuring costs, Officer or director change
Jul 13, 2022 Jul 13, 2022
8-K Current report
Other events
Jul 6, 2022 Jul 6, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 15, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
Apr 14, 2022 Apr 11, 2022
8-K Current report
Officer or director change
Mar 23, 2022 Mar 23, 2022
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Officer or director change
Feb 14, 2022 Feb 14, 2022
8-K Current report
Officer or director change
Feb 7, 2022 Feb 2, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change
Oct 4, 2021 Sep 29, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Shareholder vote results
Jun 22, 2021 Jun 16, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
8-K Current report
Officer or director change
Mar 4, 2021 Feb 26, 2021
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Other events
Jan 25, 2021 Jan 20, 2021
8-K Current report
Results of operations, Other events
Jan 19, 2021 Jan 19, 2021
8-K Current report
Officer or director change
Dec 22, 2020 Dec 16, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 6, 2020 Oct 6, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 23, 2020 Jun 17, 2020
8-K Current report
Other events
May 29, 2020 May 29, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
8-K Current report
Officer or director change
Apr 28, 2020 Apr 27, 2020
8-K Current report
Other events
Mar 30, 2020 Mar 30, 2020
8-K Current report
Material agreement
Mar 24, 2020 Mar 23, 2020
8-K Current report
Officer or director change
Mar 23, 2020 Mar 23, 2020
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Officer or director change
Feb 20, 2020 Feb 14, 2020
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Officer or director change
Aug 29, 2019 Aug 28, 2019
8-K Current report
Officer or director change
Aug 22, 2019 Aug 19, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K/A Amended current report
Officer or director change
Jun 21, 2019 Dec 19, 2018
8-K Current report
Shareholder vote results
Jun 21, 2019 Jun 19, 2019
8-K Current report
Officer or director change
May 29, 2019 May 22, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
8-K Current report
Officer or director change
Apr 22, 2019 Apr 17, 2019
8-K Current report
Material agreement, Unregistered share sale
Apr 8, 2019 Apr 2, 2019
8-K Current report
Officer or director change
Mar 25, 2019 Mar 20, 2019
8-K Current report
Results of operations
Feb 27, 2019 Feb 27, 2019
8-K Current report
Regulation FD disclosure
Feb 26, 2019 Feb 26, 2019
8-K Current report
Officer or director change
Jan 31, 2019 Jan 25, 2019
8-K Current report
Officer or director change
Dec 20, 2018 Dec 19, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
8-K Current report
Regulation FD disclosure
Oct 22, 2018 Oct 22, 2018
8-K Current report
Results of operations
Aug 8, 2018 Aug 8, 2018
8-K Current report
Other events
Jul 17, 2018 Jul 12, 2018
8-K Current report
Results of operations
Jul 10, 2018 Jul 10, 2018
8-K Current report
Shareholder vote results
Jun 15, 2018 Jun 13, 2018
8-K Current report
Other events
Jun 4, 2018 Jun 4, 2018
8-K Current report
Other events
May 22, 2018 May 22, 2018
8-K Current report
Regulation FD disclosure
May 16, 2018 May 16, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
8-K Current report
Results of operations
Mar 7, 2018 Mar 7, 2018
8-K Current report
Officer or director change
Jan 29, 2018 Jan 24, 2018
8-K Current report
Regulation FD disclosure
Jan 8, 2018 Jan 8, 2018
8-K Current report
Officer or director change
Dec 4, 2017 Dec 1, 2017
8-K Current report
Other events
Nov 28, 2017 Nov 28, 2017
8-K Current report
Results of operations
Nov 7, 2017 Nov 7, 2017
8-K Current report
Officer or director change
Oct 24, 2017 Oct 23, 2017
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 3, 2017 Sep 29, 2017
8-K Current report
Results of operations
Aug 7, 2017 Aug 7, 2017
8-K Current report
Auditor change
Jul 17, 2017 Jul 12, 2017
8-K Current report
Other events
Jun 29, 2017 Jun 29, 2017
8-K Current report
Other events
Jun 28, 2017 Jun 28, 2017
8-K Current report
Shareholder vote results
Jun 21, 2017 Jun 20, 2017
8-K Current report
Officer or director change
May 15, 2017 May 12, 2017
8-K Current report
Results of operations
May 5, 2017 May 5, 2017
8-K Current report
Officer or director change
Mar 30, 2017 Mar 29, 2017
8-K Current report
Material agreement, Regulation FD disclosure
Mar 20, 2017 Mar 17, 2017
8-K Current report
Results of operations
Mar 2, 2017 Mar 2, 2017
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2017 Jan 10, 2017
8-K Current report
Other events
Dec 14, 2016 Dec 14, 2016
8-K Current report
Other events
Dec 13, 2016 Dec 13, 2016
8-K Current report
Other events
Dec 5, 2016 Dec 5, 2016
8-K Current report
Results of operations
Nov 3, 2016 Nov 3, 2016
8-K Current report
Results of operations
Aug 3, 2016 Aug 3, 2016
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2016 Jun 10, 2016
8-K Current report
Results of operations
May 6, 2016 May 6, 2016
8-K Current report
Officer or director change
Apr 28, 2016 Apr 26, 2016
8-K Current report
Material agreement, Regulation FD disclosure
Apr 21, 2016 Apr 21, 2016
8-K Current report
Results of operations, Officer or director change
Mar 7, 2016 Mar 1, 2016
8-K Current report
Regulation FD disclosure
Feb 22, 2016 Feb 12, 2016
8-K Current report
Other events
Jan 20, 2016 Jan 20, 2016
8-K Current report
Material agreement, New debt
Dec 16, 2015 Dec 10, 2015
8-K Current report
Results of operations
Nov 23, 2015 Nov 23, 2015
8-K Current report
Bylaw or fiscal year change, Other events
Oct 19, 2015 Oct 14, 2015

Showing 133 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CTMX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer
SEC CIK
1501989

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.